Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Evogene Ltd. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 16 | 14 | −2 |
| Shares | 130.4K | 154.3K | +23.9K (+18.3%) |
| Value | $166.9K | $176.1K | +$9.16K (+5.5%) |
New holders (1)
Institutions that held Evogene Ltd. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altshuler Shaham Ltd | 750 | $856 | 0.00% |
Sold out (3)
Institutions that held Evogene Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 32,017 | $41.0K |
| Raymond James Financial Inc | 200 | $256 |
| US Bancorp | 15 | $19 |